Skip to main content
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.110
+0.020 (1.83%)
At close: Mar 6, 2026, 4:00 PM EST
1.106
-0.004 (-0.36%)
After-hours: Mar 6, 2026, 7:58 PM EST

Humacyte Revenue

Humacyte had revenue of $753.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $1.57M.

Revenue (ttm)
$1.57M
Revenue Growth
n/a
P/S Ratio
136.36
Revenue / Employee
$7,141
Employees
220
Market Cap
214.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20221.57M302.00K23.91%
Dec 31, 20211.26M-228.00K-15.29%
Dec 31, 20201.49M-4.70M-75.90%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Arcturus Therapeutics Holdings 82.03M
Protalix BioTherapeutics 61.84M
Voyager Therapeutics 31.32M
Alector 21.05M
Sol-Gel Technologies 18.97M
MediWound 16.96M
Cibus 3.79M
Revenue Rankings

HUMA News

More News